SON-mediated gene expression and leukemia
SON介导的基因表达和白血病
基本信息
- 批准号:10214098
- 负责人:
- 金额:$ 22.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-12-01 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Leukemia is the most common and devastating cancer affecting children and young adults with high mortality rate. Mutations and altered expression of numerous transcription factors, RNA splicing factors and epigenetic modifiers have been identified in leukemia patients, indicating that dysregulation of gene expression machinery is a hallmark of leukemia. SON is a poorly characterized nuclear protein highly expressed in blood cells, and the critical role of SON in RNA splicing of cell cycle- and pluripotency-related genes was recently identified. Besides its RNA-binding ability and the function as a splicing mediator, SON has also been shown to repress transcription of a few mammalian genes. However, the mechanisms of SON-mediated transcriptional regulation and the disease relevance of SON functions are largely unknown. Our preliminary data from SON ChIP-seq analyses revealed that SON interacts with multiple genomic locations to suppress transcription of target genes which include critical factors associated with hematopoiesis, stem cell maintenance and leukemogenesis. Interestingly, SON knockdown results in increased tri-methylation of lysine 4 on histone H3 (H3K4me3), eliciting gene activation at SON-targeted promoters. We also found that the C-terminus of SON containing RNA-binding motifs is necessary to suppress promoter activity, and identified several candidates of SON-interacting non-coding RNAs. More interestingly, SON E, a short SON isoform lacking RNA-binding motifs, is highly expressed in leukemia. In addition, SON E exhibits a dominant negative effect on full-length SON function in transcriptional repression, while enhancing full-length SON-mediated RNA splicing. Based on our preliminary data, we hypothesize that the SON complex containing RNA components suppresses target gene activation through regulating histone modifications, and upregulation of SON E (a short isoform) causes alterations in SON target gene expression and enhances hematopoietic stem cell self-renewal, which facilitates leukemogenesis. To test this hypothesis, we propose following specific aims; (1) To elucidate the molecular mechanisms of SON-mediated transcriptional repression. (2) To investigate the effect of SON E upregulation on gene expression, proliferation and self-renewal in hematopoietic stem cells. (3) To identify the role of SON E in leukemogenesis. Investigation of the function of SON and its short isoform in controlling gene expression and leukemogenesis will generate valuable mechanistic insights into a novel mode of fine-tuning of gene expression, and reveal new therapeutic targets for leukemia and other hematopoietic malignancies.
描述(由申请人提供):白血病是影响儿童和年轻人的最常见和最具破坏性的癌症,死亡率很高。在白血病患者中已经鉴定出许多转录因子、RNA剪接因子和表观遗传修饰剂的突变和改变的表达,表明基因表达机制的失调是白血病的标志。SON是一种在血细胞中高度表达的核蛋白,其在细胞周期和多能性相关基因的RNA剪接中的关键作用最近被确定。除了其RNA结合能力和作为剪接介质的功能外,SON还被证明抑制一些哺乳动物基因的转录。然而,SON介导的转录调控机制和SON功能的疾病相关性在很大程度上是未知的。我们来自SON ChIP-seq分析的初步数据显示,SON与多个基因组位置相互作用以抑制靶基因的转录,这些靶基因包括与造血、干细胞维持和白血病发生相关的关键因子。有趣的是,SON敲低导致组蛋白H3(H3 K4 me 3)上赖氨酸4的三甲基化增加,引发SON靶向启动子处的基因激活。我们还发现,SON的C-末端含有RNA结合基序是抑制启动子活性所必需的,并确定了几个候选的SON相互作用的非编码RNA。更有趣的是,SON E,一种缺乏RNA结合基序的短SON同种型,在白血病中高度表达。此外,SON E在转录抑制中对全长SON功能表现出显性负效应,同时增强全长SON介导的RNA剪接。基于我们的初步数据,我们假设含有RNA组分的SON复合物通过调节组蛋白修饰来抑制靶基因活化,并且SON E(一种短亚型)的上调导致SON靶基因表达的改变并增强造血干细胞自我更新,这有利于白血病发生。为了验证这一假设,我们提出了以下具体目标:(1)阐明SON介导的转录抑制的分子机制。(2)目的探讨SON E表达上调对造血干细胞基因表达、增殖和自我更新的影响。(3)目的探讨SON E在白血病发生中的作用。SON及其短亚型在控制基因表达和白血病发生中的功能的研究将产生有价值的机制的见解到一个新的模式的基因表达的微调,并揭示白血病和其他造血系统恶性肿瘤的新的治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Erin Eun-Young Ahn其他文献
Erin Eun-Young Ahn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Erin Eun-Young Ahn', 18)}}的其他基金
Genetic and molecular basis of hematopoietic abnormalities in ZTTK syndrome
ZTTK 综合征造血异常的遗传和分子基础
- 批准号:
10644169 - 财政年份:2023
- 资助金额:
$ 22.44万 - 项目类别:
SON-mediated RNA splicing in glioblastoma
胶质母细胞瘤中SON介导的RNA剪接
- 批准号:
10428558 - 财政年份:2020
- 资助金额:
$ 22.44万 - 项目类别:
SON-mediated RNA splicing in glioblastoma
胶质母细胞瘤中SON介导的RNA剪接
- 批准号:
10206064 - 财政年份:2020
- 资助金额:
$ 22.44万 - 项目类别:
SON-mediated RNA splicing in glioblastoma
胶质母细胞瘤中SON介导的RNA剪接
- 批准号:
10621200 - 财政年份:2020
- 资助金额:
$ 22.44万 - 项目类别:
SON and the MALAT1 locus in chromatin interaction and metastasis gene regulation
SON 和 MALAT1 位点在染色质相互作用和转移基因调控中的作用
- 批准号:
8813728 - 财政年份:2014
- 资助金额:
$ 22.44万 - 项目类别:
SON and the MALAT1 locus in chromatin interaction and metastasis gene regulation
SON 和 MALAT1 位点在染色质相互作用和转移基因调控中的作用
- 批准号:
8976834 - 财政年份:2014
- 资助金额:
$ 22.44万 - 项目类别:
相似国自然基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
- 批准号:82372275
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
- 批准号:82300356
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
Tom1L1在胞内体蛋白分选机制中功能的研究
- 批准号:31171289
- 批准年份:2011
- 资助金额:56.0 万元
- 项目类别:面上项目
溶酶体依赖性TRAF2降解的机制
- 批准号:30971501
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
相似海外基金
CAREER: Understanding and engineering DNA supercoiling-mediated feedback in gene circuits
职业:理解和改造基因回路中 DNA 超螺旋介导的反馈
- 批准号:
2339986 - 财政年份:2024
- 资助金额:
$ 22.44万 - 项目类别:
Continuing Grant
Gut microbiome-mediated differences within the pre-malignant mammary tissue environment enhance early breast tumor metastasis
恶变前乳腺组织环境中肠道微生物介导的差异增强了早期乳腺肿瘤转移
- 批准号:
10594667 - 财政年份:2023
- 资助金额:
$ 22.44万 - 项目类别:
SEMA6D-mediated breast cancer disparity, metastasis, and tumor-immune interaction
SEMA6D 介导的乳腺癌差异、转移和肿瘤免疫相互作用
- 批准号:
10634959 - 财政年份:2023
- 资助金额:
$ 22.44万 - 项目类别:
eCD4-mediated control of SIV infection in the brain
eCD4 介导的脑部 SIV 感染控制
- 批准号:
10698442 - 财政年份:2023
- 资助金额:
$ 22.44万 - 项目类别:
The Renin-Angiotensin System in Air Pollution-Mediated Exacerbation of Obesity.
空气污染介导的肥胖加剧中的肾素-血管紧张素系统。
- 批准号:
10654124 - 财政年份:2023
- 资助金额:
$ 22.44万 - 项目类别:
Heme-mediated Mitochondrial Injury, Senescence, Acute Kidney Injury and Chronic Kidney Disease
血红素介导的线粒体损伤、衰老、急性肾损伤和慢性肾病
- 批准号:
10656648 - 财政年份:2023
- 资助金额:
$ 22.44万 - 项目类别:
Reversal of Ovarian Aging in Mice Through AAV-mediated Oocyte Reprogramming in vivo
通过 AAV 介导的体内卵母细胞重编程逆转小鼠卵巢衰老
- 批准号:
10723227 - 财政年份:2023
- 资助金额:
$ 22.44万 - 项目类别:
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
- 批准号:
10724882 - 财政年份:2023
- 资助金额:
$ 22.44万 - 项目类别:
SMC1A/3 cohesin complex-mediated silencing of unintegrated HIV-1 DNA and the antagonism by Vpr
SMC1A/3粘连蛋白复合物介导的未整合HIV-1 DNA的沉默和Vpr的拮抗作用
- 批准号:
10760648 - 财政年份:2023
- 资助金额:
$ 22.44万 - 项目类别:
Stress Granule Formation in the Antiretroviral-Mediated Dysregulation of Oligodendrocyte Maturation in HIV-HAND
HIV-HAND 中抗逆转录病毒介导的少突胶质细胞成熟失调中的应激颗粒形成
- 批准号:
10762118 - 财政年份:2023
- 资助金额:
$ 22.44万 - 项目类别: